Reducing variability among treatment machines using knowledge-based planning for head and neck, pancreatic, and rectal cancer
- PMID: 34151503
- PMCID: PMC8292706
- DOI: 10.1002/acm2.13316
Reducing variability among treatment machines using knowledge-based planning for head and neck, pancreatic, and rectal cancer
Abstract
Purpose: This study aimed to assess dosimetric indices of RapidPlan model-based plans for different energies (6, 8, 10, and 15 MV; 6- and 10-MV flattening filter-free), multileaf collimator (MLC) types (Millennium 120, High Definition 120, dual-layer MLC), and disease sites (head and neck, pancreatic, and rectal cancer) and compare these parameters with those of clinical plans.
Methods: RapidPlan models in the Eclipse version 15.6 were used with the data of 28, 42, and 20 patients with head and neck, pancreatic, and rectal cancer, respectively. RapidPlan models of head and neck, pancreatic, and rectal cancer were created for TrueBeam STx (High Definition 120) with 6 MV, TrueBeam STx with 10-MV flattening filter-free, and Clinac iX (Millennium 120) with 15 MV, respectively. The models were used to create volumetric-modulated arc therapy plans for a 10-patient test dataset using all energy and MLC types at all disease sites. The Holm test was used to compare multiple dosimetric indices in different treatment machines and energy types.
Results: The dosimetric indices for planning target volume and organs at risk in RapidPlan model-based plans were comparable to those in the clinical plan. Furthermore, no dose difference was observed among the RapidPlan models. The variability among RapidPlan models was consistent regardless of the treatment machines, MLC types, and energy.
Conclusions: Dosimetric indices of RapidPlan model-based plans appear to be comparable to the ones based on clinical plans regardless of energies, MLC types, and disease sites. The results suggest that the RapidPlan model can generate treatment plans independent of the type of treatment machine.
Keywords: different treatment machine; disease site; energy; knowledge-based planning; multileaf collimator type.
© 2021 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals LLC on behalf of American Association of Physicists in Medicine.
Figures
References
-
- Moore KL, Brame RS, Low DA, Mutic S. Experience‐based quality control of clinical intensity‐modulated radiotherapy planning. Int J Radiat Oncol Biol Phys. 2011;81:545–551. - PubMed
-
- Fogliata A, Belosi F, Clivio A, et al. On the pre‐clinical validation of a commercial model‐based optimisation engine: application to volumetric modulated arc therapy for patients with lung or prostate cancer. Radiother Oncol. 2014;113:385–391. - PubMed
-
- Hussein M, South CP, Barry MA, et al. Clinical validation and benchmarking of knowledge‐based IMRT and VMAT treatment planning in pelvic anatomy. Radiother Oncol. 2016;120:473–479. - PubMed
-
- Scaggion A, Fusella M, Roggio A, et al. Reducing inter‐ and intra‐planner variability in radiotherapy plan output with a commercial knowledge‐based planning solution. Phys Med. 2018;53:86–93. - PubMed
